QQ客服 官方微博 反馈留言

	The efficacy and safety of cilostazol as an alternative to aspirin in Chinese patients with aspirin intolerance after coronary stent implantation: a combined clinical study and computational system pharmacology analysis
	Xue, Ying; Feng, Zhi-wei; Li, Xiao-ye; Hu, Zi-heng; Xu, Qing; Wang, Zi; Cheng, Jia-hui; Shi, Hong-tao; Wang, Qi-bing; Wu, Hong-yi
刊名	ACTA PHARMACOLOGICA SINICA
	2018
卷号	39期号:2
关键词	dual antiplatelet therapy aspirin intolerance cilostazol percutaneous coronary intervention major adverse cardiac events network system pharmacology
ISSN号	1671-4083
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3604938
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Xue, Ying,Feng, Zhi-wei,Li, Xiao-ye,et al. The efficacy and safety of cilostazol as an alternative to aspirin in Chinese patients with aspirin intolerance after coronary stent implantation: a combined clinical study and computational system pharmacology analysis[J]. ACTA PHARMACOLOGICA SINICA,2018,39(2).
APA	Xue, Ying.,Feng, Zhi-wei.,Li, Xiao-ye.,Hu, Zi-heng.,Xu, Qing.,...&Lv, Qian-zhou.(2018).The efficacy and safety of cilostazol as an alternative to aspirin in Chinese patients with aspirin intolerance after coronary stent implantation: a combined clinical study and computational system pharmacology analysis.ACTA PHARMACOLOGICA SINICA,39(2).
MLA	Xue, Ying,et al."The efficacy and safety of cilostazol as an alternative to aspirin in Chinese patients with aspirin intolerance after coronary stent implantation: a combined clinical study and computational system pharmacology analysis".ACTA PHARMACOLOGICA SINICA 39.2(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。